Sutro Biopharma Inc buy Wedbush
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€7.38
Performance (%)
-26.78%
Price
07.05.24
€3.56
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -26.78%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 13.291% | 13.291% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-23.58%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.08
14.11.23
14.11.23
€11.07
14.11.24
14.11.24
68.27%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.72
23.10.23
23.10.23
€11.29
23.10.24
23.10.24
27.94%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.86
11.08.23
11.08.23
€10.95
11.08.24
11.08.24
-7.77%
07.05.24
07.05.24